This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bio-Reference Laboratories Inc (BRLI)

NASDAQ: Health Care

Company Income Statement
Oct 2013 Oct 2012 Oct 2011 Oct 2010
Sales 715.35M 661.66M 558.64M 458.02M
Cost of Sales 377.22M 324.54M 276.82M 223.60M
Gross Operating Profit 338.14M 337.12M 281.82M 234.42M
Selling, General, and Administrative Expenses 236.42M 244.32M 207.05M 174.23M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 101.71M 92.79M 74.78M 60.20M
Depreciation & Amortization 19.74M 16.66M 15.00M 11.82M
Interest Income 118.00K 163.00K 163.00K 151.00K
Other Income - Net 612.00K -323.00K 6.66M 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 82.70M 75.97M 66.59M 48.53M
Interest Expense 1.61M 1.46M 1.75M 1.57M
Pre-Tax Income 81.10M 74.52M 64.85M 46.96M
Income Taxes 35.27M 32.36M 28.49M 20.58M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 45.82M 42.16M 36.36M 26.38M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 45.82M 42.16M 36.36M 26.38M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 45.82M 42.16M 36.36M 26.38M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
45.82M 42.16M 36.36M 26.38M
Preferred Dividends
Net Income Available To Common 45.82M 42.16M 36.36M 26.38M
Basic EPS from Continuing Ops. 1.65 1.52 1.30 0.95
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.65 1.52 1.30 0.95
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.65 1.52 1.30 0.95
Basic Normalized Net Income/Share 1.65 1.52 1.30 0.95
EPS fr Continuing Ops. 1.65 1.51 1.29 0.94
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.65 1.51 1.29 0.94
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.65 1.51 1.29 0.94
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.65 1.51 1.29 0.94
Dividends Paid per Share 0.00 0.00 0.00 0.00
BRLI News

BRLI Bio-Reference Laboratories Inc

Analysts Ratings for BRLI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 0 0 0
Strong Sell 0 0 0 0
GET BRLI ANALYST REPORT

Brokerage Partners

BRLI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs